Valuation: Celltrion Pharm, Inc.

Market Cap 4,674B 6,825,212B 4,105B 3,817B 3,503B 6,582B 450,081B 6,683B 45,331B 17,710B 221,275B 17,545B 17,167B 765,063B P/E 2019
166x
P/E 2020 417x
Enterprise Value 4,837B 7,063,649B 4,248B 3,951B 3,625B 6,812B 465,804B 6,917B 46,915B 18,329B 229,005B 18,158B 17,767B 791,790B EV / Sales 2019
9.06x
EV / Sales 2020 38x
Free-Float
44.4%
Yield 2019 *
-
Yield 2020 -
1 day+3.46%
1 week+1.51%
Current month-1.22%
1 month-2.42%
3 months-30.70%
6 months-36.38%
Current year-30.34%
1 week 37,800
Extreme 37800
41,200
1 month 37,800
Extreme 37800
43,300
Current year 37,800
Extreme 37800
78,300
1 year 37,800
Extreme 37800
78,300
3 years 37,800
Extreme 37800
124,463.12
5 years 37,800
Extreme 37800
146,932.97
10 years 13,660.97
Extreme 13660.9749
221,035.48
Manager TitleAgeSince
Chief Executive Officer 61 25/03/2024
Director of Finance/CFO 53 -
Sales & Marketing 55 -
Director TitleAgeSince
Chairman 68 27/03/2025
Chairman 42 25/03/2024
Director/Board Member 61 25/03/2024
Date Insider Type Main position Quantity % Market Cap.
07/05/25 Fiscal year 4,500 0.0103%
07/05/25 Others 24 0.0001%
07/05/25 Others 127 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+3.46%+1.51%-24.11%-46.11% 1.22B
-0.66%+0.44%+14.72%+76.40% 48.36B
+2.20%+1.41%+61.04%+111.43% 35.8B
+1.26%-0.57%-5.20%+34.48% 11.83B
-0.46%-3.06%+14.15%+80.63% 11.48B
-0.37%-0.37%+37.89%+137.78% 9.01B
+1.52%+0.39%+48.79%-5.82% 6.99B
-0.17%-2.92%+13.13%+30.45% 6.7B
-0.59%-1.95%+2.23%+178.07% 6.42B
-7.92%-13.61%-34.97%-4.08% 5.3B
Average -0.17%-1.34%+12.77%+59.32% 14.31B
Weighted average by Cap. +0.15%-0.40%+24.93%+80.27%

Financials

2019 2020
Net sales 174B 253,389B 152B 142B 130B 244B 16,709B 248B 1,683B 658B 8,215B 651B 637B 28,403B 234B 341,092B 205B 191B 175B 329B 22,493B 334B 2,265B 885B 11,058B 877B 858B 38,234B
Net income 8.6B 12,562B 7.56B 7.03B 6.45B 12.11B 828B 12.3B 83.43B 32.6B 407B 32.29B 31.6B 1,408B 20.94B 30,579B 18.39B 17.1B 15.69B 29.49B 2,017B 29.94B 203B 79.35B 991B 78.61B 76.91B 3,428B
Net Debt 149B 216,940B 130B 121B 111B 209B 14,306B 212B 1,441B 563B 7,033B 558B 546B 24,318B 163B 238,437B 143B 133B 122B 230B 15,723B 233B 1,584B 619B 7,730B 613B 600B 26,727B
Logo Celltrion Pharm, Inc.
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Employees
328
Date Price Change Volume
24/07/26 ₩40,400.00 +3.46% 113,075
23/07/26 ₩39,050.00 +2.76% 106,060
22/07/26 ₩38,000.00 -0.65% 62,491
21/07/26 ₩38,250.00 0.00% 82,063
20/07/26 ₩38,250.00 -3.89% 66,097
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A068760 Stock